Problematica de la infeccion por el virus de la hepatitis C en donantes de sangre. Evaluacion clinico-epidemiologica, virologica e histologica

Medicina

Volumn 57, Issue 6, 1997, Pages 699-707

  Sookoian, Silvia ^a,c   Castaño, Gustavo ^a   Castiglioni, Teresa ^a   Pilar, Silvia ^a   Viudez, Pedro ^a   Gonzalez, Jorge ^b   Frider, Bernardo ^a  

^a Hospital Municipal General de Agudos   (Argentina)

^b Instituto Nacional de Microbiologia Dr Carlos GMalbran   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY; RNA;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; BLOOD; BLOOD DONOR; CASE CONTROL STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; LIVER; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; BIOPSY; BLOOD DONORS; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RNA; TRANSAMINASES;

EID: 0031300609     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M, et al. Isolation of a cDNA clone derived from a blood borne Non-A, non-B hepatitis genome. Science 1989; 244: 362-4.
2. Alter HJ, Purcell RH, Shih JW, Melplder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med 1989; 321: 1491-500.
3. Donahue JG, Muñoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-73.
4. González A, Esteban JY, Madoz P, Vitadomiu L, Genesca J, Muñiz E, et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion associated hepatitis: Final report of a prospective trial. Hepatology 1995; 22: 439-45
5. Frider B, Sookoian S, Castaño G, Kina M, Viudez P, Castiglioni T. Risk Factors in Chronic HCV carriers of Buenos Aires Metropolitan Area. Hepatology 1995; 22 (4 Pt 2); 349 A.
6. Serfaty L, Giral P, Elghouzzi ME, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody Elisa-positive blood donors according to RIBA-2 status: A case-control survey. Hepatology 1993; 17: 183-7.
7. Simoyama R, Sekiguchi S, Suga M, Sakamoto S, Yachi A. The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations. Gastroent Jap 1993; 28 (Suppl 5): 1-5.
8. Abate ML, Manzina P, Negro F, Baldi M, Saracco G, Piantino P, et al. Detection of hepatitis C virus RNA by reverse transcriptase and polymerase chain reaction: clinical applications of quantitative analysis. Clinical and Virology. 1994; 1: 289-97.
9. Menghini G. One-second biopsy of the liverproblems of clinical application. N Engl J Med 1970; 283: 582.
10. Frider B, Castaño G, Ŕbora N, Sookoian S. BlopSia hepática percutánea: procedimiento ambulatorio? Acta Gastroenterol Latinoam, 1993; 59: 1211.
11. Knodell RG, Ishak KG, Black WC, Cheu TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns N, Scheuer P. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
13. Dawson Saunders B, Trapp RG. Bioestadistica médica. México, 1993.
14. McSween RN, Anthony PP, Scheuer PJ, Burt AD, Portman BC. Pathology of the liver. London: Churchill Livingstone, 1994.
15. Prevalencia del anti-HCV en donantes de sangre. Informe de la Dirección de Epidemiología, Secretaria de Salud Publica de la Municipalidad de Buenos Aires, 1994.
16. McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McCaughan GW. Detection of serum hepatitis C Virus RNA in HCV antibody-sero-positive volunteer blood donors. Hepatology 1993; 18: 485-90.
17. Goodrick MJ, Anderson NAB, Fraser ID, Rouse A, Pearson V. History of previous drug misuse in HCV positive blood donors. Lancet 1992; 339: 502.
18. Kolho EK, Krusius T. Risk factors for Hepatitis C Virus antibody positivy in blood donors in a low risk country. Vox Sang 1992; 63: 192-7.
19. Alonso C, Pedroso ML, San José S, Montcharmont P, Chèvre JM, Boucaud MJ, et al. Hepatitis C Virus among blood donors. Follow-up study. Transfusion 1994; 34: 527-30.
20. Esteban JI, López-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muñiz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to Hepatitis C Virus. Ann Intern Med 1991; 115: 443-9.
21. O'Connor PG, Selwyn PA, Schottenfeld RS. Medical care for injection-drug users with human immunodeficiency virus infection. N Engl J Med 1994; 331: 450-9.
22. Conry-Cantinela C, Vanraden M, Gibble J, Melpolder J, Shakil AO, Viladomiu, L et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
23. Aliter MJ, Margolis HS, Krawczynski K, Hudson F, Mares A, Alexander J, et al. Natural history of community-acquired Hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
24. Findor JA, Frider B, Bruch Igartua E, Rey J, Sookoian S. Castaño G. Prevalence of antibodies to hepatitis C virus (Anti-HCV) by 2nd. Generation Enzyme immunoassay (EIA) in hemodialysis units. Confirmations by line-immunoassay (Liatek). International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 1996; 228.
25. Van Thiel D, Caraceni P, Molloy PJ, Hassanein T, Kania RJ, Gurakar A, et al. Chronic Hepatitis C in patients with normal or near normal alanine aminotransferase levels; the role of interferon alfa-2b therapy. Hepatology 1995; 23: 503-8.
26. Silva AE, Hosein B, Boyle R, Fang C, Shindo M, Waggoner JG, et al. Diagnosis of chronic hepatitis C: Comparison of immuno-assays and the polymerase chain reaction. Am J Gastroenterol 1994; 89: 493-6.
27. Anderson SC, Hathaway T, Kuramoto IK, Holland PV, Giicher R, Koch T, et al. Comparison of two secondgeneration anti-hepatitis C virus Elisa on 21431 US blood donors samples. J Viral Hepatitis 1995; 2: 55-61.
28. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98-104.
29. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel JN, Gerken G, Lelie PN, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-4.
30. Prieto M, Olaso V, Verdú C, Córdoba J, Gisbert C, Rayón M, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology 1995; 22: 413-7.
31. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.